Home
Products
Gene
mRNA Products
mRNAs for Cancer Vaccine Research
mRNAs for Cancer Vaccine Research

mRNAs for Cancer Vaccine Research

Seattle Genova is one of the leading providers of life sciences products, offering a wide range of products, including mRNA services. Advancement in therapeutic medicine, mRNA has remarkably outcast everything to solve puzzles in the research field. With the increasing demand for mRNA and the help of Ph.D. experts, Seattle Genova has succeeded in developing services on mRNAs for cancer vaccine research. We provide high-quality cost-friendly products to meet our customer’s needs. Seattle Genova offers antibodies, bioactive proteins, virus particles, mRNA products, Stable cell lines, and research use kits in this category.  

Compare
Catalog Number
Gene Name
Product Name
More
CD40L
CD40L Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0011
CD40L Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CD40L was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0011-LNP
CD40L Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
FGF2
FGF2 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0012
FGF2 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding FGF2 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0012-LNP
FGF2 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
hGCC-PADRE
hGCC-PADRE Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0013
hGCC-PADRE Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding hGCC-PADRE was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0013-LNP
hGCC-PADRE Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
B7-1
B7-1 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0014
B7-1 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding B7-1 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0014-LNP
B7-1 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Her-2/neu
Her-2/neu Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0015
Her-2/neu Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Her-2/neu was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0015-LNP
Her-2/neu Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Tyrosinase/MART-1/MAGEA6
Tyrosinase/MART-1/MAGEA6 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0016
Tyrosinase/MART-1/MAGEA6 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Tyrosinase/MART-1/MAGEA6 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0016-LNP
Tyrosinase/MART-1/MAGEA6 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
ERBB2
ERBB2 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0017
ERBB2 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding ERBB2 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0017-LNP
ERBB2 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Interleukin-12
Interleukin-12 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0018
Interleukin-12 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Interleukin-12 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0018-LNP
Interleukin-12 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
TP53
TP53 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0019
TP53 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding TP53 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0019-LNP
TP53 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
PSA
PSA Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0020
PSA Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding PSA was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0020-LNP
PSA Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Choose up to 4 products to compare
Compare
Clear All
0.216986s